T-cell subset biomarkers across the rheumatoid arthritis disease continuum: from clinical utility to adoption in daily practice
The biomarker potential of CD4+T cell subsets (naive, regulatory (Treg), inflammation-related cells (IRC)) in patients with rheumatoid arthritis (RA) has been described. OBJECTIVE: This article investigates the dynamic changes in these biomarkers across the RA disease continuum…